Children's Advil Ad Ban Is Proper, J&J Unit Tells 2nd. Circ.

Law360, New York (January 11, 2017, 1:26 PM EST) -- A New York federal judge was right to find a decades-old order stopping Pfizer from promoting Advil’s risk of stomach damage as comparable to Tylenol’s also applies to Children’s Advil because the order focuses on the drug itself, not the brand, a Johnson & Johnson unit told the Second Circuit on Tuesday.

U.S. District Judge Andrew L. Carter’s April decision in favor of Tylenol-maker McNeil-PPC Inc. — now Johnson & Johnson Consumer Inc. — should be upheld because U.S. District Judge William C. Conner’s 1989 order...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Pfizer Inc. v. McNeil-PPC, Inc.


Case Number

16-1743

Court

Appellate - 2nd Circuit

Nature of Suit

3890 STATUTES-Other

Date Filed

May 31, 2016

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.